Jaguar Health announces special shareholder meeting
JAGX•Special shareholder meeting scheduled for Sept. 4
Jaguar Health scheduled a special shareholder meeting in San Francisco on Sept. 4, 2026.
- Vote on issuing common shares upon exchange of outstanding Series Q Perpetual Preferred Stock held by accredited investors.
- Consider repricing investor warrants for 60,781 common shares to an exercise price of USD 1 per share.
- Warrants, when exercised, also carry rights to receive up to 682,661 common shares tied to the Series O Preferred Stock Dividend.
- Seek approval to amend the 2014 Stock Incentive Plan to authorize share issuance up to 14% of fully diluted shares as of Sept. 30, 2026.
